Painreform Stock Technical Analysis
| PRFX Stock | USD 2.78 -0.06 -2.11% |
Market data as of the 16th of March 2026 shows Painreform priced at 2.78 per share. Measured indicators report Variance of 58.01, coefficient of variation of -1,387, and Risk Adjusted Performance of -0.05. The model examines historical data series to identify measurable trend characteristics. Technical levels are measured against peer distributions.
Painreform Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Painreform, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PainreformPainreform | Build AI portfolio with Painreform Stock |
Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 12.0 | Hold | 1 | Odds |
The summary for Painreform includes current and past analyst recommendations. The view also includes average analyst consensus. Sell-side analysts covering Painreform typically assign buy, hold, or sell ratings alongside a 12-month price target. These estimates for Painreform are revised regularly based on earnings results, guidance updates, and changes in the competitive landscape.
Investors evaluate Painreform using market value and book value, each describing different facets of the business. Painreform's market capitalization is 1.87 M. A P/B ratio of 0.26 suggests Painreform trades near or below book value. Intrinsic value reflects what Painreform's fundamentals imply about worth, which may differ from both the trading price and the book figure. Analytical frameworks help reconcile those views.
Value and price for Painreform are related but not identical, and they can diverge across cycles. For Painreform, key inputs include a P/B ratio of 0.26, and ROE of -127.65%. The quoted Painreform price is the exchange level where supply meets demand.
What if' Analysis
What-if analysis for Painreform is essentially a historical sensitivity test that shows how changes in the investment horizon could have altered realized return, drawdown, and timing outcomes. Valuation should still be reviewed through market value, enterprise value. revenue scale, and balance-sheet quality. The point is not to predict the future from one chart, but to understand how sensitive the trade has been to timing and holding assumptions.
| 12/16/2025 |
| 03/16/2026 |
Starting with 0.00 in Painreform on December 16, 2025 and exiting today would record 0.00 in total gains. In total, that is a 0.0% return on investment in Painreform on balance across 90 days. Painreform competes with or is related to Universe Pharmaceuticals, Elevai Labs, Dermata Therapeutics, Psyence Biomedical, Avenue Therapeutics, Virax Biolabs, and NewcelX. This provides context for relative positioning. PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that prov... More
Upside and Downside Indicators for Painreform Summary
Upside/downside measures for Painreform frame directional pressure and range behavior. This view helps summarize momentum conditions without implying direction.
| Information Ratio | -0.07 | |||
| Maximum Drawdown | 52.96 | |||
| Value At Risk | -12.32 | |||
| Potential Upside | 10.36 |
Market Risk Indicators for Painreform Snapshot
These indicators track Painreform's volatility and return range dynamics. The measures summarize variability without implying direction.| Risk Adjusted Performance | -0.05 | |||
| Jensen Alpha | -0.45 | |||
| Total Risk Alpha | -0.13 | |||
| Treynor Ratio | -0.23 |
Mean reversion in Painreform's price occurs when temporary dislocations - caused by sentiment extremes, news events, or liquidity shocks - correct back toward the stock's historical fair value.
Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | -0.05 | |||
| Market Risk Adjusted Performance | -0.22 | |||
| Mean Deviation | 4.94 | |||
| Coefficient Of Variation | -1,387 | |||
| Standard Deviation | 7.62 | |||
| Variance | 58.01 | |||
| Information Ratio | -0.07 | |||
| Jensen Alpha | -0.45 | |||
| Total Risk Alpha | -0.13 | |||
| Treynor Ratio | -0.23 | |||
| Maximum Drawdown | 52.96 | |||
| Value At Risk | -12.32 | |||
| Potential Upside | 10.36 | |||
| Skewness | 2.04 | |||
| Kurtosis | 9.27 |
Painreform Backtested Returns
Painreform currently shows a dangerously high risk exposure across the evaluation window. It maintains a Sharpe Ratio (Efficiency) of -0.0866, representing negative adjusted performance consistency. We identified twenty-four technical indicators influencing the company's volatility profile. Please assess metrics such as Variance of 58.01, coefficient of variation of -1,387, and risk-adjusted performance of -0.05 to validate implied volatility levels. The firm shows a Beta (market volatility) of 2.44, which alludes to a somewhat significant risk relative to the market. Market upswings tend to lift Painreform more than average, but downturns carry a proportionally larger impact on returns. At this point, Painreform has a negative expected return of -0.66%. Please make sure to double-check Painreform's relationship between the Potential Upside and day median price, to decide if Painreform's performance from the past will be repeated at some future date.
Auto-correlation | -0.07 |
Very weak reverse predictability
Painreform exhibits very weak reverse predictability. Autocorrelation measures the degree of predictability between Painreform time series from 16th of December 2025 to 30th of January 2026 and from 30th of January 2026 to 16th of March 2026. Persistent correlation between intervals suggests underlying momentum patterns in Painreform that may carry forward. The measured coefficient of -0.07 means barely 7.0% of Painreform's recent price variance traces back to prior period behavior. Given that Painreform has negative autocorrelation for the selected time horizon, market participants may evaluate potential contrarian price behavior over comparable future intervals.
| Correlation Coefficient | -0.07 | |
| Spearman Rank Test | 0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Technical analysis for Painreform evaluates price and volume patterns over time. Common inputs include moving averages, RSI, regressions, and price-return correlations.
Technical Analysis
This analysis covers thirty-seven data points across the selected time horizon. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Painreform volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Technical Analysis Methodology & Indicators
Technical analysis of Painreform evaluates price structure, momentum, and volatility clustering. Support and resistance levels frame risk boundaries for observed price regimes. Painreform has a market cap of 1.87 M, ROE of -127.65%.
This section for Painreform is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Values may update on different source schedules.
This content is curated and reviewed by:
Rifka Kats - Member of Macroaxis Editorial BoardPainreform Technical Indicators
Investors following Painreform often rely on technical indicators to test whether price action is supporting continuation, exhaustion, or a possible change in direction. Used correctly, technical indicators support timing and risk control but should still be validated against broader market and business context.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | -0.05 | |||
| Market Risk Adjusted Performance | -0.22 | |||
| Mean Deviation | 4.94 | |||
| Coefficient Of Variation | -1,387 | |||
| Standard Deviation | 7.62 | |||
| Variance | 58.01 | |||
| Information Ratio | -0.07 | |||
| Jensen Alpha | -0.45 | |||
| Total Risk Alpha | -0.13 | |||
| Treynor Ratio | -0.23 | |||
| Maximum Drawdown | 52.96 | |||
| Value At Risk | -12.32 | |||
| Potential Upside | 10.36 | |||
| Skewness | 2.04 | |||
| Kurtosis | 9.27 |
March 16, 2026 Daily Trend Indicators
Investors following Painreform often rely on technical indicators to test whether price action is supporting continuation, exhaustion, or a possible change in direction. Used correctly, technical indicators support timing and risk control but should still be validated against broader market and business context.
| Accumulation Distribution | 0.08 | ||
| Daily Balance Of Power | -0.26 | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 2.84 | ||
| Day Typical Price | 2.82 | ||
| Price Action Indicator | -0.09 | ||
| Market Facilitation Index | 0.23 |
Popular Tools for Painreform Stock analysis
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Global Correlations Find global opportunities by holding instruments from different markets |